18.3 C
New York
November 7, 2024
1st Afrika
Health

Johnson & Johnson Starts Ebola Vaccine Trial in Sierra Leone

Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.

The vaccine regimen is part of a new study being conducted in that nation’s Kambia district, where some of the country’s most recent Ebola cases have been reported.

People walk past a billboard warning residents to stop the stigmatization of Ebola survivors, in Kenema, eastern Sierra Leone on Aug. 12, 2015. /APPeople walk past a billboard warning residents to stop the stigmatization of Ebola survivors, in Kenema, eastern Sierra Leone on Aug. 12, 2015. /AP

More than 11,000 people have died from the Ebola virus since the latest outbreak emerged in late 2013, nearly all of them in West Africa in and around Sierra Leone.

There is currently no licensed vaccine, treatment or cure for Ebola.

The Johnson & Johnson study, in development at subsidiary Janssen Pharmaceutical Cos., will evaluate safety and immune response within Sierra Leone’s general population.

The company said Friday that the first volunteers have received the initial dose.

Johnson & Johnson, based in New Brunswick, New Jersey, said that there are separate studies being conducted in the U.S., Europe and Africa as part of the accelerated development plan to prevent Ebola outbreaks.

Related posts

17,774 People In Ghana Tested Positive For HIV In 2023, Majority Between 15 And 24 Years

Jide Adesina

UN General Secretary Mr .Ban To Convene Meeting Of World Leaders On Tackling Ebola Outbreak

Jide Adesina

Pharmaceutical Company to Launch Cheaper Drugs For Chronic Diseases in Kenya

Jide Adesina

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More